Baader Bank »

Arcutis Biotherapeutics shares owned by Baader Bank

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Baader Bank from 13F filings

Historical chart of Baader Bank investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Baader Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Baader Bank

Quarter filed Position value Share count Share price at filing
2025-03-31 $156k 10k 15.64

More positions owned by Baader Bank

Robinhood Mkts Com Cl A (HOOD)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Palantir Technologies Cl A (PLTR)
Meta Platforms Cl A (META)
Linde SHS (LIN)
NVIDIA Corporation (NVDA)
Adobe Systems Incorporated (ADBE)
Advanced Micro Devices (AMD)
Oracle Corporation (ORCL)
salesforce (CRM)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Thermo Fisher Scientific (TMO)

View all positions for Baader Bank

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Rubric Capital Management
Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Vanguard Group
Polar Capital Holdings
State Street Corporation
Gilder, Gagnon, Howe & Co
UBS Group
Geode Capital Management
Henderson Group
Franklin Resources
Pivotal bioVenture Partners Investment Advisor
D. E. Shaw & Co

View all funds holding Arcutis Biotherapeutics